Eur Rev Med Pharmacol Sci 2015; 19 (24): 4940-

Erratum

E.I. Cekirdekci

Department of Cardiology, Corlu State Hospital, Corlu, Turkey. ecekirdekci@yahoo.com

Reply letter “More appropriate study design is need for confirm diagnostic utility of S100A4 protein”, by E.I. Cekirdekci, published in the Eur Rev Med Pharmacol Sci 2015; 19(22): 4212-4213, PMID 26636504.

The title has been corrected in “More appropriate study design needs to confirm the diagnostic utility of S100A4 protein”.

To cite this article

E.I. Cekirdekci
Erratum

Eur Rev Med Pharmacol Sci
Year: 2015
Vol. 19 - N. 24
Pages: 4940-

Keywords Related articles:

  1. Knockdown of S100A4 chemosensitizes human laryngeal carcinoma cells in vitro through inhibition of Slug
  2. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma
  3. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal
  4. Clinicopathologic significance of S100A4 expression in osteosarcoma
  5. Serum S100A4 levels as a novel biomarker for detection of acute myocardial infarction